Glympse Bio is based in Cambridge. It has raised $69M in total funding. Latest round: Series B.
Glympse Bio funding overview
Glympse Bio is based in Cambridge. Glympse Bio has raised $69M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in July 2020. The round record for Glympse Bio runs through 2020; nothing later has been disclosed. Investors on record include Lightspeed Venture Partners, Hemisphere Ventures, Veritas Investments, F-Prime Capital, LS Polaris Innovation Fund, New Leaf Venture Partners and 3 others. 9 distinct backers are named across the disclosed rounds.
Glympse Bio has raised $69M in total disclosed funding across the rounds on record.
Who has invested in Glympse Bio?
Lightspeed Venture Partners, Hemisphere Ventures, Veritas Investments, F-Prime Capital, LS Polaris Innovation Fund, New Leaf Venture Partners are named among the investors backing Glympse Bio.
What was the latest Glympse Bio funding round?
The most recent disclosed round is a Series B, announced in July 2020.
Where is Glympse Bio based?
Glympse Bio is based in Cambridge.
When did Glympse Bio last raise?
The last disclosed Glympse Bio round closed in July 2020 at Series B.
Totals shown for Glympse Bio aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
